60dy Federal Register Notice

lotter on DSK11XQN23PROD with NOTICES1

Federal Register / Vol. 88, No. 185 / Tuesday, September 26, 2023 / Notices
the power to vote shares of a bank or
bank holding company and all of the
banks and nonbanking companies
owned by the bank holding company,
including the companies listed below.
The public portions of the
applications listed below, as well as
other related filings required by the
Board, if any, are available for
immediate inspection at the Federal
Reserve Bank(s) indicated below and at
the offices of the Board of Governors.
This information may also be obtained
on an expedited basis, upon request, by
contacting the appropriate Federal
Reserve Bank and from the Board’s
Freedom of Information Office at
https://www.federalreserve.gov/foia/
request.htm. Interested persons may
express their views in writing on the
standards enumerated in the BHC Act
(12 U.S.C. 1842(c)). If the proposal also
involves the acquisition of a nonbanking
company, the review also includes
whether the acquisition of the
nonbanking company complies with the
standards in section 4 of the BHC Act
(12 U.S.C. 1843), and interested persons
may express their views in writing on
the standards enumerated in section 4.
Unless otherwise noted, nonbanking
activities will be conducted throughout
the United States.
Comments regarding each of these
applications must be received at the
Reserve Bank indicated or the offices of
the Board of Governors, Ann E.
Misback, Secretary of the Board, 20th
Street and Constitution Avenue NW,
Washington, DC 20551–0001, not later
than October 26, 2023.
A. Federal Reserve Bank of Richmond
(Brent B. Hassell, Assistant Vice
President) 701 East Byrd Street,
Richmond, Virginia 23219. Comments
can also be sent electronically to
[email protected]:
1. Southern Bancshares (N.C.), Inc.,
Mount Olive, North Carolina; to acquire
up to 19.9 percent of the voting shares
of Old Point Financial Corporation,
Hampton, Virginia, and thereby
indirectly acquire voting shares of The
Old Point National Bank of Phoebus,
Hampton, Virginia, and Old Point Trust
& Financial Services, N.A., Newport
News, Virginia. In addition, Southern
Bancshares (N.C.), Inc., through the
acquisition of Old Point Trust &
Financial Services, N.A., will engage in
providing trust company functions and
securities brokerage services pursuant to
sections 225.28(b)(5) and (b)(7)(i) of the
Board’s Regulation Y, respectively. This
notice replaces and supersedes FR Doc
2023–62785 published on 09–13–2023.

VerDate Sep<11>2014

18:18 Sep 25, 2023

Jkt 259001

Board of Governors of the Federal Reserve
System.
Michele Taylor Fennell,
Deputy Associate Secretary of the Board.
[FR Doc. 2023–20935 Filed 9–25–23; 8:45 am]
BILLING CODE P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–23–0840; Docket No. CDC–2023–
0078]

Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:

The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other federal
agencies the opportunity to comment on
a continuing information collection, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment on a proposed information
collection project titled ‘‘Formative
Research and Tool Development’’. This
information collection request is
designed to allow CDC’s National Center
for HIV, Viral Hepatitis, STD, and TB
Prevention (NCHHSTP) to conduct
formative research information
collection activities used to inform
many aspects of surveillance,
communications, health promotion, and
research project development for
NCHHSTP’s four priority diseases (HIV/
AIDS), sexually transmitted diseases/
infections (STD/STI), viral hepatitis,
tuberculosis elimination (TB), and
school and adolescent health (DASH).
DATES: CDC must receive written
comments on or before November 27,
2023.
SUMMARY:

You may submit comments,
identified by Docket No. CDC–2023–
0078 by any of the following methods:
• Federal eRulemaking Portal:
www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS H21–8, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and

ADDRESSES:

PO 00000

Frm 00056

Fmt 4703

Sfmt 4703

66001

Docket Number. CDC will post, without
change, all relevant comments to
www.regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(www.regulations.gov) or by U.S. mail to
the address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS
H21–8, Atlanta, Georgia 30329;
Telephone: 404–639–7118; Email: omb@
cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected;
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses; and
5. Assess information collection costs.
Proposed Project
Formative Research and Tool
Development (OMB Control No. 0920–

E:\FR\FM\26SEN1.SGM

26SEN1

66002

Federal Register / Vol. 88, No. 185 / Tuesday, September 26, 2023 / Notices

0840, Exp. 7/31/2024)—Extension—
National Center for HIV, Viral Hepatitis,
STD, TB Prevention (NCHHSTP),
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
The Centers for Disease Control and
Prevention (CDC), National Center for
HIV, Viral Hepatitis, STD, and TB
Prevention (NCHHSTP) requests
approval for an Extension and a threeyear approval for the previously
approved Generic Clearance,
‘‘Formative Research and Tool
Development’’. This information
collection request is designed to allow
NCHHSTP to conduct formative
research information collection
activities used to inform many aspects
of surveillance, communications, health
promotion, and research project
development for NCHHSTP’s four
priority diseases (HIV/AIDS, sexually
transmitted diseases/infections (STD/
STI), viral hepatitis, tuberculosis
elimination and the Division of School
and Adolescent Heath (DASH)).
Formative research is the basis for
developing effective strategies including
communication channels, for
influencing behavior change. It helps
researchers identify and understand the
characteristics—interests, behaviors and
needs—of target populations that
influence their decisions and actions.
Formative research is integral in
developing programs as well as
improving existing and ongoing
programs. Formative research also looks
at the community in which a public
health intervention is being, or will be
implemented, and helps the project staff
understand the interests, attributes and
needs of different populations and
persons in that community. Formative
research is research that occurs before a
program is designed and implemented,
or while a program is being conducted.
NCHHSTP formative research is
necessary for developing new programs
or adapting programs that deal with the

health programs to assess needs related
to initiation of a new program activity
or expansion or changes in scope or
implementation of existing program
activities to adapt them to current
needs. The information collected will be
used to advise programs and provide
capacity-building assistance tailored to
identified needs.
Overall, these development activities
are intended to provide information that
will increase the success of the
surveillance or research projects
through increasing response rates and
decreasing response error, thereby
decreasing future data collection burden
to the public. The studies that will be
covered under this request will include
one or more of the following
investigational modalities: (1) structured
and qualitative interviewing for
surveillance, research, interventions and
material development; (2) cognitive
interviewing for development of specific
data collection instruments; (3)
methodological research; (4) usability
testing of technology-based instruments
and materials; (5) field testing of new
methodologies and materials; (6)
investigation of mental models for
health decision-making, to inform
health communication messages; and (7)
organizational needs assessments to
support development of capacity.
Respondents who will participate in
individual and group interviews
(qualitative, cognitive, and computer
assisted development activities) are
selected purposively from those who
respond to recruitment advertisements.
In addition to utilizing advertisements
for recruitment, respondents who will
participate in research on survey
methods may be selected purposively or
systematically from within an ongoing
surveillance or research project.
CDC requests OMB approval for an
estimated 6,657 annual burden hours.
Participation of respondents is
voluntary, and there is no cost to
participants other than their time.

complexity of behaviors, social context,
cultural identities, and health care that
underlie the epidemiology of HIV/AIDS,
viral hepatitis, STDs, and TB in the U.S,
as well as for school and adolescent
health. CDC conducts formative
research to develop public-sensitive
communication messages and userfriendly tools prior to developing or
recommending interventions, or care.
Sometimes these studies are entirely
behavioral but most often they are
cycles of interviews and focus groups
designed to inform the development of
a product.
Products from these formative
research studies will be used for
prevention of HIV/AIDS, Sexually
Transmitted Infections (STI), viral
Hepatitis, and Tuberculosis. Findings
from these studies may also be
presented as evidence to diseasespecific National Advisory Committees,
to support revisions to recommended
prevention and intervention methods, as
well as to develop new
recommendations. Much of CDC’s
health communication takes place
within campaigns that have lengthy
planning periods—timeframes that
accommodate the standard federal
process for approving data collections.
Short-term qualitative interviewing and
cognitive research techniques have
previously proven invaluable in the
development of scientifically valid and
population-appropriate methods,
interventions, and instruments.
This request includes studies
investigating the utility and
acceptability of proposed sampling and
recruitment methods, intervention
contents and delivery, questionnaire
domains, individual questions, and
interactions with project staff or
electronic data collection equipment.
These activities will also provide
information about how respondents
answer questions and ways in which
question response bias and error can be
reduced. This request also includes
collection of information from public

lotter on DSK11XQN23PROD with NOTICES1

ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents

Type of respondent

Form name

General public ...................................
Health care providers .......................
General public ...................................
Health care providers .......................
General public ...................................
Health care providers .......................
General public ...................................
Health care providers .......................
General public ...................................
Health care providers .......................

Screener ...........................................
Screener ...........................................
Consent Forms .................................
Consent Forms .................................
Individual Interview ...........................
Individual Interview ...........................
Focus Group Interview .....................
Focus Group Interview .....................
Survey of Individual ..........................
Survey of Individual ..........................

VerDate Sep<11>2014

18:18 Sep 25, 2023

Jkt 259001

PO 00000

Frm 00057

Fmt 4703

Sfmt 4703

Number of
responses per
respondent

Average hours
per response

Total response
burden
(hours)

1
1
1
1
1
1
1
1
1
1

10/60
10/60
5/60
5/60
1
1
2
2
30/60
30/60

9,473
4,060
2,368
1,015
4,620
1,980
5,600
2,400
10,500
4,500

56,840
24,360
28,420
12,180
4,620
1,980
2,800
1,200
21,000
9,000

E:\FR\FM\26SEN1.SGM

26SEN1

Federal Register / Vol. 88, No. 185 / Tuesday, September 26, 2023 / Notices

66003

ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Form name

Number of
respondents

Number of
responses per
respondent

Average hours
per response

Total response
burden
(hours)

...........................................................

........................

........................

........................

46,516

Type of respondent
Total ...........................................

Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Public Health Ethics and
Regulations, Office of Science, Centers for
Disease Control and Prevention.
[FR Doc. 2023–20761 Filed 9–25–23; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–23–1305]

Agency Forms Undergoing Paperwork
Reduction Act Review

lotter on DSK11XQN23PROD with NOTICES1

In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled ‘‘Chronic Q
Fever in the United States: Enhanced
Clinical Surveillance’’ to the Office of
Management and Budget (OMB) for
review and approval. CDC previously
published a ‘‘Proposed Data Collection
Submitted for Public Comment and
Recommendations’’ notice on June 27,
2023 to obtain comments from the
public and affected agencies. CDC
received no comments related to the
previous notice. This notice serves to
allow an additional 30 days for public
and affected agency comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;

VerDate Sep<11>2014

18:18 Sep 25, 2023

Jkt 259001

(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570.
Comments and recommendations for the
proposed information collection should
be sent within 30 days of publication of
this notice to www.reginfo.gov/public/
do/PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. Direct written
comments and/or suggestions regarding
the items contained in this notice to the
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
comments within 30 days of notice
publication.
Proposed Project
Chronic Q Fever in the United States:
Enhanced Clinical Surveillance (OMB
Control No. 0920–1305, Exp. 9/30/
2023)—Revision—National Center for
Emerging and Zoonotic Infectious
Diseases (NCEZID), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
Q fever is a worldwide zoonosis
caused by Coxiella burnetii with acute
and chronic disease presentations.
Chronic Q fever can manifest months to
years after the primary infection and is
rare, occurring in <5% of persons with
an acute infection. Chronic Q fever can

PO 00000

Frm 00058

Fmt 4703

Sfmt 4703

take on several clinical forms, including
endocarditis, chronic hepatitis, chronic
vascular infections, osteomyelitis, and
osteoarthritis. In the United States, Q
fever cases are reported via the National
Notifiable Disease Surveillance System;
however, limited information is
collected on the various clinical
manifestations of chronic Q fever or
patients pre-existing risk factors. Data
on outcomes other than death or
hospitalizations are not collected by the
current surveillance. Because of this
lack of data, the true burden and
proportion of cases exhibiting
endocarditis and other forms of chronic
Q fever in the United States is
unknown. We plan to establish an
enhanced medical surveillance for
chronic Q fever by working with
consulting clinicians to gather
additional and more specific clinical
data not otherwise collected during the
course of routine public health
surveillance for chronic Q fever. This
information will allow for better
characterization of the clinical
presentation and risk factors of chronic
Q fever in the United States. The results
will help characterize an underrecognized disease and provide valuable
data to educate physicians on
identifying and diagnosing these cases.
Recently, there has been an increased
volume of clinical consultation requests.
To reflect this, we are proposing an
increase in the number of respondents
to 50 each year. Additionally, the
clinical course for these patients is often
complex, and clinical relapse or
prolonged infection has been reported.
To capture these important clinical
details, we propose increasing the
number of total instruments to two, with
a follow-up survey that will take five
minutes each at six, 12, 18, and 24
months from the date of the initial
consult.
CDC requests OMB approval for an
estimated 34 annual burden hours.
There is no cost to respondents other
than their time to participate.

E:\FR\FM\26SEN1.SGM

26SEN1